The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Jules L. Dienstag

Gastrointestinal Unit

Massachusetts General Hospital

and the Department of Medicine

Harvard Medical School

USA

[email]@partners.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Gastrointestinal Unit, Massachusetts General Hospital, and the Department of Medicine, Harvard Medical School, USA. 1999 - 2011
  • Gastrointestinal Unit, Liver-Biliary-Pancreas Center, Massachusetts General Hospital, Boston, USA. 1999 - 2007

References

  1. A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Dienstag, J.L., Ghany, M.G., Morgan, T.R., Di Bisceglie, A.M., Bonkovsky, H.L., Kim, H.Y., Seeff, L.B., Szabo, G., Wright, E.C., Sterling, R.K., Everson, G.T., Lindsay, K.L., Lee, W.M., Lok, A.S., Morishima, C., Stoddard, A.M., Everhart, J.E. Hepatology (2011) [Pubmed]
  2. Benefits and risks of nucleoside analog therapy for hepatitis B. Dienstag, J.L. Hepatology (2009) [Pubmed]
  3. Hepatitis B virus infection. Dienstag, J.L. N. Engl. J. Med. (2008) [Pubmed]
  4. Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients. Dienstag, J.L., Wei, L.J., Xu, D., Kreter, B. Clin. Drug. Investig (2007) [Pubmed]
  5. Histological outcome during long-term lamivudine therapy. Dienstag, J.L., Goldin, R.D., Heathcote, E.J., Hann, H.W., Woessner, M., Stephenson, S.L., Gardner, S., Gray, D.F., Schiff, E.R. Gastroenterology (2003) [Pubmed]
  6. Durability of serologic response after lamivudine treatment of chronic hepatitis B. Dienstag, J.L., Cianciara, J., Karayalcin, S., Kowdley, K.V., Willems, B., Plisek, S., Woessner, M., Gardner, S., Schiff, E. Hepatology (2003) [Pubmed]
  7. The role of liver biopsy in chronic hepatitis C. Dienstag, J.L. Hepatology (2002) [Pubmed]
  8. Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. Dienstag, J.L., Schiff, E.R., Mitchell, M., Casey, D.E., Gitlin, N., Lissoos, T., Gelb, L.D., Condreay, L., Crowther, L., Rubin, M., Brown, N. Hepatology (1999) [Pubmed]
  9. Lamivudine as initial treatment for chronic hepatitis B in the United States. Dienstag, J.L., Schiff, E.R., Wright, T.L., Perrillo, R.P., Hann, H.W., Goodman, Z., Crowther, L., Condreay, L.D., Woessner, M., Rubin, M., Brown, N.A. N. Engl. J. Med. (1999) [Pubmed]
 
WikiGenes - Universities